NewAmsterdam Pharma Co. NV (NAMS)
NewAmsterdam Pharma Market Cap : 3.529B for Jan. 30, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| uniQure NV | 1.415B |
| ProQR Therapeutics NV | 170.66M |
| argenx SE | 51.75B |
| Pharming Group NV | 1.402B |
| Pharvaris NV | 1.757B |
Market Cap Related Metrics
| PS Ratio | 99.50 |
| PEG Ratio | -2.353 |
| Price to Book Value | 4.847 |
| Price | 31.12 |
| Earnings Yield | -6.56% |
| PEGY Ratio | -2.353 |